Legacy Private Trust Co. Has $3.74 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Legacy Private Trust Co. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 128.8% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 7,778 shares of the healthcare conglomerate’s stock after purchasing an additional 4,378 shares during the quarter. Legacy Private Trust Co.’s holdings in UnitedHealth Group were worth $3,738,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Chesapeake Wealth Management increased its position in UnitedHealth Group by 7.0% during the 4th quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock worth $2,647,000 after buying an additional 326 shares during the period. Westhampton Capital LLC increased its position in shares of UnitedHealth Group by 1.2% in the first quarter. Westhampton Capital LLC now owns 2,587 shares of the healthcare conglomerate’s stock worth $1,223,000 after purchasing an additional 30 shares during the period. Two Sigma Investments LP bought a new position in shares of UnitedHealth Group in the fourth quarter worth $87,114,000. Sendero Wealth Management LLC increased its position in shares of UnitedHealth Group by 10.8% in the first quarter. Sendero Wealth Management LLC now owns 6,210 shares of the healthcare conglomerate’s stock worth $2,935,000 after purchasing an additional 607 shares during the period. Finally, Alta Capital Management LLC increased its position in shares of UnitedHealth Group by 335.1% in the first quarter. Alta Capital Management LLC now owns 62,712 shares of the healthcare conglomerate’s stock worth $29,637,000 after purchasing an additional 48,300 shares during the period. Institutional investors and hedge funds own 85.69% of the company’s stock.

UnitedHealth Group Stock Up 0.6 %

Shares of NYSE:UNH opened at $486.70 on Friday. The stock has a market cap of $450.83 billion, a price-to-earnings ratio of 21.78, a PEG ratio of 1.42 and a beta of 0.66. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.68. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $558.10. The business’s 50 day moving average is $491.55 and its 200 day moving average is $486.55.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping the consensus estimate of $5.92 by $0.22. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The business had revenue of $92.90 billion for the quarter, compared to analysts’ expectations of $90.97 billion. During the same quarter in the previous year, the firm earned $5.57 earnings per share. The business’s revenue was up 15.6% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 33.65%.

Insiders Place Their Bets

In other news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the transaction, the chief executive officer now owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $564.00 to $555.00 in a research note on Monday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Thursday. Wells Fargo & Company cut their price objective on UnitedHealth Group from $616.00 to $561.00 in a research note on Thursday, July 13th. Mizuho lowered their target price on UnitedHealth Group from $600.00 to $549.00 in a report on Tuesday, July 11th. Finally, Stephens reiterated an “overweight” rating and issued a $560.00 target price on shares of UnitedHealth Group in a report on Friday, August 11th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $575.65.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.